Cynthia A. Rossi
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Cynthia A. Rossi has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
- Aimee I. Porter
United States Army Military Research Institute of Infectious Diseases (USAMRIID); Center for Aerobiological Sciences; Frederick, MD USA
1 shared publication - Fredrick Ogolla
Centre for Infectious and Parasitic Disease Control Research, Kenya Medical Research Institute, Busia P.O. Box 3-50400, Kenya
1 shared publication - Lillian A Musila
Department of Emerging Infectious Diseases, United States Army Medical Research Unit-Kenya/Kenya Medical Research Institute, Nairobi, P.O. Box 29893-00202, Kenya
1 shared publication - Luis DaSilva
Center for Aerobiological Sciences; US Army Medical Research Institute of Infectious Diseases (USAMRIID); Frederick MD USA
1 shared publication - Luke E. Mease
US Army Combined Joint Task Force–1, Bagram Air Field, Afghanistan
1 shared publication - Nicholas Adungo
Centre for Infectious and Parasitic Disease Control Research, Kenya Medical Research Institute, Busia P.O. Box 3-50400, Kenya
1 shared publication
Latest Publications
- Open Access
- 1 August 2012
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 8 (8) , 1053-1065
Host responses to live-attenuated Venezuelan equine encephalitis virus (TC-83)
Venezuelan equine encephalitis virus (VEEV) is a positive-strand RNA Alphavirus endemic in Central and South America, and the causative agent of fatal encephalitis in humans. In an effort to better understand the mechanisms of infection, including differences between people who produce a neutralizing antibody response to the vaccine and those who do not, we performed whole genome transcriptional analysis in human PBMCs exposed in vitro to the live-attenuated vaccine strain of VEEV, TC-83. We compared the molecular responses in cells from three groups of individuals: naïve; previously vaccinated individuals who developed a neutralizing antibody response to the vaccine (responders); and those who did not develop a neutralizing antibody response to the vaccine (nonresponders). Overall, the changes in gene expression were more intense for the naïve group after TC-83 challenge and least potent in the nonresponder group. The main canonical pathways revealed the involvement of interferon and interferon-induced pathways, as well as toll-like receptors TLR- and interleukin (IL)-12-related pathways. HLA class II genotype and suppression of transcript expression for TLR2, TLR4 and TLR8 in the nonresponder group may help explain the lack of vaccine response in this study group. Because TL3 and TLR7 transcripts were elevated in all study groups, these factors may be indicators of the infection and not the immunological state of the individuals. Biomarkers were identified that differentiate between the vaccine responder and the vaccine nonresponder groups. The identified biomarkers were contrasted against transcripts that were unique to the naïve population alone upon induction with TC-83. Biomarker analysis allowed for the discernment between the naïve (innate) responses; the responder (recall) responses; and the nonresponder (alternative) changes to gene transcription that were caused by infection with TC-83. The study also points to the existence of HLA haplotypes that may discriminate between vaccine low- and high-responder phenotypes.
- 1 August 2012
- Published by Taylor & Francis in Human Vaccines & Immunotherapeutics
- Vol. 8 (8) , 1053-1065
Open AccessHost responses to live-attenuated Venezuelan equine encephalitis virus (TC-83)
Venezuelan equine encephalitis virus (VEEV) is a positive-strand RNA Alphavirus endemic in Central and South America, and the causative agent of fatal encephalitis in humans. In an effort to better understand the mechanisms of infection, including differences between people who produce a neutralizing antibody response to the vaccine and those who do not, we performed whole genome transcriptional analysis in human PBMCs exposed in vitro to the live-attenuated vaccine strain of VEEV, TC-83. We compared the molecular responses in cells from three groups of individuals: naïve; previously vaccinated individuals who developed a neutralizing antibody response to the vaccine (responders); and those who did not develop a neutralizing antibody response to the vaccine (nonresponders). Overall, the changes in gene expression were more intense for the naïve group after TC-83 challenge and least potent in the nonresponder group. The main canonical pathways revealed the involvement of interferon and interferon-induced pathways, as well as toll-like receptors TLR- and interleukin (IL)-12-related pathways. HLA class II genotype and suppression of transcript expression for TLR2, TLR4 and TLR8 in the nonresponder group may help explain the lack of vaccine response in this study group. Because TL3 and TLR7 transcripts were elevated in all study groups, these factors may be indicators of the infection and not the immunological state of the individuals. Biomarkers were identified that differentiate between the vaccine responder and the vaccine nonresponder groups. The identified biomarkers were contrasted against transcripts that were unique to the naïve population alone upon induction with TC-83. Biomarker analysis allowed for the discernment between the naïve (innate) responses; the responder (recall) responses; and the nonresponder (alternative) changes to gene transcription that were caused by infection with TC-83. The study also points to the existence of HLA haplotypes that may discriminate between vaccine low- and high-responder phenotypes.
- Open Access
- 27 July 2011
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 371
Seroprevalence and distribution of arboviral infections among rural Kenyan adults: A cross-sectional study
Arthorpod-borne viruses (arboviruses) cause wide-spread morbidity in sub-Saharan Africa, but little research has documented the burden and distribution of these pathogens.
- 27 July 2011
- Published by Springer Nature in Virology Journal
- Vol. 8 (1) , 371
Open AccessSeroprevalence and distribution of arboviral infections among rural Kenyan adults: A cross-sectional study
Arthorpod-borne viruses (arboviruses) cause wide-spread morbidity in sub-Saharan Africa, but little research has documented the burden and distribution of these pathogens.